Internal Medicine, Hematology · Atlanta, GA
NPI
1083145593
Since 2017
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1364 Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-0519
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
224 services
Medicare patients, 2024
52
Average age 73
Drug cost, 2024
$2.0M
486 prescriptions
Company payments, 2025
$351
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Hochman was code 99215 (office e&m - established), 42 times for 17 patients. In total Michael J Hochman billed 224 services in 17 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 42 | 17 | $107.42 | $4,512 |
| 99233 Hospital E&M - Subsequent | Facility | 36 | 17 | $89.16 | $3,210 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 25 | 12 | $21.44 | $536 |
| 99214 Office E&M - Established | Office | 19 | 11 | $79.57 | $1,512 |
| 99213 Office E&M - Established | Office | 16 | 12 | $55.20 | $883 |
By year: 2023 $6,740 for 82 services; 2024 $16K for 224 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Hochman prescribed most often to Medicare patients was Hydroxyurea, with 35 prescriptions and refills. In total Michael J Hochman wrote 486 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 35 | 51 | 13 | $1,855 |
| Valacyclovir Valacyclovir Hcl | 27 | 67 | 16 | $1,372 |
| Venclexta Venetoclax | 26 | 26 | Under 11 | $151K |
| Besremi Ropeginterferon Alfa-2b-Njft | 22 | 24 | Under 11 | $375K |
| Jakafi Ruxolitinib Phosphate | 19 | 19 | Under 11 | $332K |
| Atorvastatin Calcium Generic | 17 | 27 | Under 11 | $178 |
| Posaconazole Generic | 17 | 17 | Under 11 | $22K |
| Pantoprazole Sodium Generic | 16 | 32 | Under 11 | $69.87 |
| Famotidine Generic | 15 | 25 | Under 11 | $88.64 |
| Tretinoin Generic | 14 | 14 | Under 11 | $24K |
| Eliquis Apixaban | 13 | 13 | Under 11 | $7,483 |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $55.4 |
| Furosemide Generic | 12 | 14 | Under 11 | $3.47 |
| Levofloxacin Generic | 12 | 16 | Under 11 | $184 |
| Potassium Chloride Generic | 11 | 13 | Under 11 | $209 |
Brand drugs: - claims; generic drugs: 333 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Hochman $351 ($351 in general payments such as food, travel and fees) from 5 companies. The largest payer was Rigel Pharmaceuticals, Inc. with $109.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.